Deb Schrag
机构: Memorial Sloan Kettering
每年引用次数
引用次数
引用: 65,129
H-指数: 119
I10-指数 : 336
出版物: 690
Costs and cost-effectiveness of colorectal cancer prevention and therapy.
J Weeks , D Schrag
Seminars in Oncology 26 ( 5) 561 -568
16
1999
PCN13 COST-EFFECTIVENESS OF HEPATIC ARTERY INFUSION FOR METASTATIC COLORECTAL CANCER (CALGB 9481)
JC Weeks , D Romanus , JE Herndon , D Schrag
Value in Health 8 ( 6)
2
2005
PCN122 DEVELOPMENT OF THE PATIENT-REPORTED VERSION OF THE COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (PRO-CTCAE)
E Basch , B Reeve , C Cleeland , J Sloan
Value in Health 13 ( 7)
150
2010
A phase II study of exatecan mesylate (DX-8951f) in advanced pancreatic cancer.
E O'Reilly , L Hammond , R Donehower , G Schwartz
Smpte Journal 11 63 -63
5
2000
Demographic differences contribute to disparities in outcomes between low and high volume centers in patients undergoing surgery for rectal cancer
S Savatta , G Melton , D Schrag , R Arons
DISEASES OF THE COLON & RECTUM 48 ( 3) 612 -613
2005
Gender differences in sexual and bladder function exist in patients undergoing sphincter preserving surgery for rectal cancer
S Savatta , G Melton , P Paty , J Guillem
DISEASES OF THE COLON & RECTUM 47 ( 4) 571 -571
2004
Validity testing of a computer model for calculating carrier probabilities of BRCA1 and BRCA2 mutations.
EH Hiller , G Parmigiani , DA Berry , AB Chittenden
AMERICAN JOURNAL OF HUMAN GENETICS 61 ( 4) A221 -A221
5
1997
1270P Genomic alterations of bone metastases in stage IV non-small cell lung cancer (NSCLC) and real-world outcomes
PJ Voon , GJ Riely , EM Lepisto , JA Lavery
Annals of Oncology 32 S992 -S992
2021
474P Genomic characterization and clinical outcomes of patients (pts) with metastatic colorectal cancer (mCRC) with peritoneal metastases (PM) in AACR project GENIE
E Sanz Garcia , GJ Riely , EM Lepisto , ML LeNoue-Newton
Annals of Oncology 32 S567 -S568
2021
Impact of prophylactic surgery on life expectancy for women with breast cancer and BRCA1/2 mutations
D Schrag , KM Kuntz , JE Garber , JC Weeks
MEDICAL DECISION MAKING 18 ( 4) 465 -465
1998
Benefits of colonoscopic surveillance and prophylactic colectomy in mutation carriers for hereditary non-polyposis coloroctal cancer
S Syngal , JC Weeks , D Schrag , JE Garber
GASTROENTEROLOGY-BALTIMORE THEN PHILADELPHIA- 112 A664 -A664
1997
597P Surgical quality for patients (pts) treated with neoadjuvant chemotherapy vs chemoradiation for locally advanced rectal cancer (LARC): PROSPECT (NCCTG N1048, alliance)
M Weiser , Q Shi , GJ Chang , L Hakki
Annals of Oncology 34 S431 -S432
2023
Cost-effectiveness projections of FOLFOX vs. IFL in first-line therapy of metastatic colorecial cancer in the context of the US health care system.
BE Hillner , D Schrag , DJ Sargent , CS Fuchs
JOURNAL OF CLINICAL ONCOLOGY 23 ( 16) 253S -253S
2005
Dynamic contrast enhanced-MRI for the detection of pathological complete response to neoadjuvant chemotherapy for locally advanced rectal cancer
MJ Gollub , DH Gultekin , O Akin , RK Do
European Radiology 22 ( 4) 821 -831
160
2012
Neoadjuvant FOLFOX-bev, without radiation, for locally advanced rectal cancer.
D Schrag , MR Weiser , KA Goodman , M Gonen
Journal of Clinical Oncology 28 3511 -3511
56
2010
Disenrollment From Medicare Managed Care Among Beneficiaries With and Without a Cancer Diagnosis
EB Elkin , N Ishill , GF Riley , PB Bach
JOURNAL OF UROLOGY 181 ( 2) 792 -792
2009
Disenrollment from Medicare managed care: Does a cancer diagnosis make a difference?
EB Elkin , NM Ishill , GF Riley , PB Bach
Journal of Clinical Oncology 26 6582 -6582
2008
Germline, somatic and clinical associations with response to Immune Checkpoint Inhibitors and adverse events in a large patient cohort
S Groha , S Abou Alaiwi , K Taraszka , E Lepisto
EUROPEAN JOURNAL OF HUMAN GENETICS 28 ( SUPPL 1) 92 -92
2020
903O A prospective study of a multi-cancer early detection blood test
D Schrag , CH McDonnell , L Nadauld , CA Dilaveri
Annals of Oncology 33 S961 -S961
32
2022
The PATHFINDER Study: Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test into Clinical Practice. Cancers. 2021; 13: 3501
LD Nadauld , CH McDonnell 3rd , TM Beer , MC Liu
DOI: https://doi. org/10.3390/cancers13143501
11
2021